<H1>Chapter DOI: 10.1186/s12974-016-0613-8<br/>Cited-By Count: 0</H1><table border="1" width="30%"><tr><td>Total References</td><td>75</td></tr><tr><td>Springer references</td><td>5</td></tr><tr><td>Non Springer references</td><td>70</td></tr><tr><td>BibStructured Count</td><td width="10%">75</td></tr><tr><td>BibUnstructured Count</td><td width="10%">0</td></tr><tr><td>DOI already available in SpringerLink</td><td>64</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>2</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>2</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>2</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>He F, Sun YE. Glial cells more than support cells? Int J Biochem Cell Biol. 2007;39(4):661&#8211;5.</td><td><a href=http://dx.doi.org/10.1016/j.biocel.2006.10.022>10.1016/j.biocel.2006.10.022</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Nedergaard M, Ransom B, Goldman SA. New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci. 2003;26(10):523&#8211;30.</td><td><a href=http://dx.doi.org/10.1016/j.tins.2003.08.008>10.1016/j.tins.2003.08.008</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Brown AM, Ransom BR. Astrocyte glycogen and brain energy metabolism. Glia. 2007;55(12):1263&#8211;71.</td><td><a href=http://dx.doi.org/10.1002/glia.20557>10.1002/glia.20557</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Dong Y, Benveniste EN. Immune function of astrocytes. Glia. 2001;36(2):180&#8211;90.</td><td><a href=http://dx.doi.org/10.1002/glia.1107>10.1002/glia.1107</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Olney JW, Sharpe LG, Feigin RD. Glutamate-induced brain damage in infant primates. J Neuropathol Exp Neurol. 1972;31(3):464&#8211;88.</td><td><a href=http://dx.doi.org/10.1097/00005072-197207000-00006>10.1097/00005072-197207000-00006</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Anderson CM, Swanson RA. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia. 2000;32(1):1&#8211;14.</td><td><a href=http://dx.doi.org/10.1002/1098-1136(200010)32:1&lt;1::AID-GLIA10&gt;3.0.CO;2-W>10.1002/1098-1136(200010)32:1&lt;1::AID-GLIA10&gt;3.0.CO;2-W</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron. 1996;16(3):675&#8211;86.</td><td><a href=http://dx.doi.org/10.1016/S0896-6273(00)80086-0>10.1016/S0896-6273(00)80086-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Bristol LA, Rothstein JD. Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex. Ann Neurol. 1996;39(5):676&#8211;9.</td><td><a href=http://dx.doi.org/10.1002/ana.410390519>10.1002/ana.410390519</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med. 1992;326(22):1464&#8211;8.</td><td><a href=http://dx.doi.org/10.1056/NEJM199205283262204>10.1056/NEJM199205283262204</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Mattson MP, Chan SL. Neuronal and glial calcium signaling in Alzheimer&#8217;s disease. Cell Calcium. 2003;34(4-5):385&#8211;97.</td><td><a href=http://dx.doi.org/10.1016/S0143-4160(03)00128-3>10.1016/S0143-4160(03)00128-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Sardar AM, Hutson PH, Reynolds GP. Deficits of NMDA receptors and glutamate uptake sites in the frontal cortex in AIDS. Neuroreport. 1999;10:3513&#8211;15.</td><td><a href=http://dx.doi.org/10.1097/00001756-199911260-00009>10.1097/00001756-199911260-00009</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>V&#225;zquez-Santiago FJ, Noel Jr RJ, Porter JT, Rivera-Amill V. Glutamate metabolism and HIV-associated neurocognitive disorders. J Neurovirol. 2014;20(4):315&#8211;31.</td><td><a href=http://dx.doi.org/10.1007/s13365-014-0258-2>10.1007/s13365-014-0258-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Chao CC, Hu S, Ehrlich L, Peterson PK. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun. 1995;9(4):355&#8211;65.</td><td><a href=http://dx.doi.org/10.1006/brbi.1995.1033>10.1006/brbi.1995.1033</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Korn T, Magnus T, Jung S. Autoantigen specific T cells inhibit glutamate uptake in astrocytes by decreasing expression of astrocytic glutamate transporter GLAST: a mechanism mediated by tumor necrosis factor-alpha. FASEB J. 2005;19(13):1878&#8211;80.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1096/fj.05-3748fje>10.1096/fj.05-3748fje</a></td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, Year</td><td>CrossRef</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Hu S, Sheng WS, Ehrlich LC, Peterson PK, Chao CC. Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation. 2000;7(3):153&#8211;9.</td><td><a href=http://dx.doi.org/10.1159/000026433>10.1159/000026433</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Zou JY, Crews FT. TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition. Brain Res. 2005;1034(1-2):11&#8211;24.</td><td><a href=http://dx.doi.org/10.1016/j.brainres.2004.11.014>10.1016/j.brainres.2004.11.014</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Ensoli F, Fiorelli V, Lugaresi A, Farina D, De Cristofaro M, Collacchi B, Muratori DS, Scala E, Di Gioacchino M, Paganelli R, Aiuti F. Lymphomononuclear cells from multiple sclerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors alpha and beta, and interferon gamma. Mult Scler. 2002;8(4):284&#8211;8.</td><td><a href=http://dx.doi.org/10.1191/1352458502ms817oa>10.1191/1352458502ms817oa</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Ruprecht K, Kuhlmann T, Seif F, Hummel V, Kruse N, Br&#252;ck W, Rieckmann P. Effects of oncostatin M on human cerebral endothelial cells and expression in inflammatory brain lesions. J Neuropathol Exp Neurol. 2001;60(11):1087&#8211;98.</td><td><a href=http://dx.doi.org/10.1093/jnen/60.11.1087>10.1093/jnen/60.11.1087</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Reale M, Iarlori C, Gambi F, Lucci I, Salvatore M, Gambi D. Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1&#946; and interleukin-6 release from lymphocytes of Alzheimer&#8217;s disease patients. Exp Gerontol. 2005;40:165&#8211;71.</td><td><a href=http://dx.doi.org/10.1016/j.exger.2004.12.003>10.1016/j.exger.2004.12.003</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Vecchiet J, Dalessandro M, Falasca K, Di lorio A, Travasi F, Zingariello P, Schiavone C, Ensoli F, Pizzigallo E, Paganelli R. Increased production of oncostatin-M by lymphomononuclear cells from HIV-1-infected patients with neuroAIDS. J Acquir Immune Defic Syndr. 2003;32(4):464&#8211;5.</td><td><a href=http://dx.doi.org/10.1097/00126334-200304010-00019>10.1097/00126334-200304010-00019</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Larochelle C, Alvarez JI, Prat A. How do immune cells overcome the blood-brain barrier in multiple sclerosis? FEBS Lett. 2011;585(23):3770&#8211;80.</td><td><a href=http://dx.doi.org/10.1016/j.febslet.2011.04.066>10.1016/j.febslet.2011.04.066</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Takata F, Sumi N, Nishioku T, Harada E, Wakigawa T, Shuto H, Yamauchi A,Kataoka Y. Oncostatin M induces functional and structural impairment of blood-brain barriers comprised of rat brain capillary endothelial cells. Neurosci Lett. 2008;441:163&#8211;6.</td><td><a href=http://dx.doi.org/10.1016/j.neulet.2008.06.030>10.1016/j.neulet.2008.06.030</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Baker BJ, Park KW, Qin H, Ma X, Benveniste EN. IL-27 inhibits OSM-mediated TNF-&#945; and iNOS gene expression in microglia. Glia. 2010;58(9):1082&#8211;93.</td><td><a href=http://dx.doi.org/10.1002/glia.20989>10.1002/glia.20989</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Wallace PM, MacMaster JF, Rouleau KA, Brown TJ, Loy JK, Donaldson KL, Wahl AF. Regulation of inflammatory responses by oncostatin M. J Immunol. 1999;162(9):5547&#8211;55.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Richards CD, Langdon C, Botelho F, Brown TJ, Agro A. Oncostatin M inhibits IL-1-induced expression of IL-8 and granulocyte-macrophage colony-stimulating factor by synovial and lung fibroblasts. J Immunol. 1996;156(1):343&#8211;9.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Moidunny S, Dias RB, Wesseling E, Sekino Y, Boddeke HW, Sebasti&#227;o AM, Biber K. Interleukin-6-type cytokines in neuroprotection and neuromodulation: oncostatin M, but not leukemia inhibitory factor, requires neuronal adenosine A<Subscript>1</Subscript> receptor function. J Neurochem. 2010;114(6):1667&#8211;77.</td><td><a href=http://dx.doi.org/10.1111/j.1471-4159.2010.06881.x>10.1111/j.1471-4159.2010.06881.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Weiss TW, Samson AL, Niego B, Daniel PB, Medcalf RL. Oncostatin M is a neuroprotective cytokine that inhibits excitotoxic injury <Emphasis Type="Italic">in vitro</Emphasis> and <Emphasis Type="Italic">in vivo</Emphasis>. FASEB J. 2006;20(13):2369&#8211;71.</td><td><a href=http://dx.doi.org/10.1096/fj.06-5850fje>10.1096/fj.06-5850fje</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Guo S, Li ZZ, Gong J, Xiang M, Zhang P, Zhao GN, Li M, Zheng A, Zhu X, Lei H, Minoru T, Li H. Oncostatin M confers neuroprotection against ischemic stroke. J Neurosci. 2015;35(34):12047&#8211;62.</td><td><a href=http://dx.doi.org/10.1523/JNEUROSCI.1800-15.2015>10.1523/JNEUROSCI.1800-15.2015</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Ensoli F, Fiorelli V, De Cristofaro M, Muratori DS, Novi A, Vannelli B, Thiele CJ, Luzi G, Aiuti F. Inflammatory cytokines and HIV-1-associated neurodegeneration: oncostatin-M produced by mononuclear cells from HIV-1-infected individuals induces apoptosis of primary neurons. J Immunol. 1999;162(10):6268&#8211;77.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Repovic P, Mi K, Benveniste EN. Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide. Glia. 2003;42(4):433&#8211;46.</td><td><a href=http://dx.doi.org/10.1002/glia.10182>10.1002/glia.10182</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Baker BJ, Qin H, Benveniste EN. Molecular basis of oncostatin M-induced SOCS-3 expression in astrocytes. Glia. 2008;56(11):1250&#8211;62.</td><td><a href=http://dx.doi.org/10.1002/glia.20694>10.1002/glia.20694</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Robson MJ, Turner RC, Naser ZJ, McCurdy CR, O&#8217;Callaghan JP, Huber JD, Matsumoto RR. SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation. J Exp Neurol. 2014;254:180&#8211;9.</td><td><a href=http://dx.doi.org/10.1016/j.expneurol.2014.01.020>10.1016/j.expneurol.2014.01.020</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Sriram K, Benkovic SA, Hebert MA, Miller DB, O&#8217;Callaghan JP. Induction of -related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis <Emphasis Type="Italic">in vivo</Emphasis>? J Biol Chem. 2004;279(19):19936&#8211;47.</td><td><a href=http://dx.doi.org/10.1074/jbc.M309304200>10.1074/jbc.M309304200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Korzus E, Nagase H, Rydell R, Travis J. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression. J Biol Chem. 1997;272(2):1188&#8211;96.</td><td><a href=http://dx.doi.org/10.1074/jbc.272.2.1188>10.1074/jbc.272.2.1188</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR35</td><td>BibArticle</td><td>Van Wagoner NJ, Choi C, Repovic P, Benveniste EN. Oncostatin M regulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38. J Neurochem. 2000;75(2):563&#8211;75.</td><td><a href=http://dx.doi.org/10.1046/j.1471-4159.2000.0750563.x>10.1046/j.1471-4159.2000.0750563.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR36</td><td>BibArticle</td><td>Kordula T, Rydel RE, Brigham EF, Horn F, Heinrich PC, Travis J. Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate alpha1-antichymotrypsin expression in human cortical astrocytes. J Biol Chem. 1998;273(7):4112&#8211;8.</td><td><a href=http://dx.doi.org/10.1074/jbc.273.7.4112>10.1074/jbc.273.7.4112</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR37</td><td>BibArticle</td><td>Abraham CR, Selkoe DJ, Potter H. Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer&#8217;s disease. Cell. 1988;52(4):487&#8211;501.</td><td><a href=http://dx.doi.org/10.1016/0092-8674(88)90462-X>10.1016/0092-8674(88)90462-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR38</td><td>BibArticle</td><td>Selkoe DJ. The molecular pathology of Alzheimer&#8217;s disease. Neuron. 1991;6(4):487&#8211;98.</td><td><a href=http://dx.doi.org/10.1016/0896-6273(91)90052-2>10.1016/0896-6273(91)90052-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR39</td><td>BibArticle</td><td>He H, Sharer LR, Chao W, Gu CJ, Borjabad A, Hadas E, Kelschenbach J, Ichiyama K, Do M, Potash MJ, Volsky DJ. Enhanced human immunodeficiency v&#237;rus type 1 expression and neuropathogenesis in knockout mice lacking type 1 interferon responses. J Neuropathol Exp Neurol. 2014;73(1):59&#8211;71.</td><td><a href=http://dx.doi.org/10.1097/NEN.0000000000000026>10.1097/NEN.0000000000000026</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR40</td><td>BibArticle</td><td>Potash MJ, Chao W, Bentsman G, Paris N, Saini M, Nitkiewicz J, Belem P, Sharer L, Brooks AI, Volsky DJ. A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness. Proc Natl Acad Sci U S A. 2005;102(10):3760&#8211;5.</td><td><a href=http://dx.doi.org/10.1073/pnas.0500649102>10.1073/pnas.0500649102</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR41</td><td>BibArticle</td><td>Matos M, Augusto E, Oliveira CR, Agostinho P. Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades. Neuroscience. 2008;156(4):898&#8211;910.</td><td><a href=http://dx.doi.org/10.1016/j.neuroscience.2008.08.022>10.1016/j.neuroscience.2008.08.022</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR42</td><td>BibArticle</td><td>Saura J. Microglial cells in astroglial cultures: a cautionary note. J Neuroinflammation. 2007;4:26.</td><td><a href=http://dx.doi.org/10.1186/1742-2094-4-26>10.1186/1742-2094-4-26</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR43</td><td>BibArticle</td><td>Hamby ME, Uliasz TF, Hewett SJ, Hewett JA. Characterization of an improved procedure for the removal of microglia from confluent monolayers of primary astrocytes. J Neurosci Methods. 2006;150(1):128&#8211;37.</td><td><a href=http://dx.doi.org/10.1016/j.jneumeth.2005.06.016>10.1016/j.jneumeth.2005.06.016</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR44</td><td>BibArticle</td><td>Moidunny S, Vinet J, Wesseling E, Bijzet J, Shieh CH, van Ijzendoorn SC, Bezzi P, Boddeke HW, Biber K. Adenosine A<Subscript>2B</Subscript> receptor-mediated leukemia inhibitory factor release from astrocytes protects cortical neurons against excitotoxicity. J Neuroinflammation. 2012;9:198.</td><td><a href=http://dx.doi.org/10.1186/1742-2094-9-198>10.1186/1742-2094-9-198</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR45</td><td>BibArticle</td><td>Biber K, Pinto-Duarte A, Wittendorp MC, Dolga AM, Fernandes CC, Von Frijtag Drabbe K&#252;nzel J, Keijser JN, de Vries R, Ijzerman AP, Ribeiro JA, Eisel U, Sebasti&#227;o AM, Boddeke HW. Interleukin-6 upregulates neuronal adenosine A<Subscript>1</Subscript> receptors: implications for neuromodulation and neuroprotection. Neuropsychopharmacology. 2008;33(9):2237&#8211;50.</td><td><a href=http://dx.doi.org/10.1038/sj.npp.1301612>10.1038/sj.npp.1301612</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR46</td><td>BibArticle</td><td>Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001;25(4):402&#8211;8.</td><td><a href=http://dx.doi.org/10.1006/meth.2001.1262>10.1006/meth.2001.1262</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR47</td><td>BibArticle</td><td>Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with Image J. J Biophotonics International. 2004;11(7):36&#8211;42.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR48</td><td>BibArticle</td><td>Bender AS, Woodbury DM, White HS. The rapid L- and D-aspartate uptake in cultured astrocytes. Neurochem Res. 1997;22(6):721&#8211;6.</td><td><a href=http://dx.doi.org/10.1023/A:1027358211472>10.1023/A:1027358211472</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR49</td><td>BibArticle</td><td>Danbolt NC. Glutamate uptake. Prog Neurobiol. 2001;65(1):1&#8211;105.</td><td><a href=http://dx.doi.org/10.1016/S0301-0082(00)00067-8>10.1016/S0301-0082(00)00067-8</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR50</td><td>BibArticle</td><td>Furness DN, Dehnes Y, Akhtar AQ, Rossi DJ, Hamann M, Grutle NJ, Gundersen V, Holmseth S, Lehre KP, Ullensvang K, Wojewodzic M, Zhou Y, Attwell D, Danbolt NC. A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes: new insights into a neuronal role for excitatory amino acid transporter 2 (EAAT2). Neuroscience. 2008;157(1):80&#8211;94.</td><td><a href=http://dx.doi.org/10.1016/j.neuroscience.2008.08.043>10.1016/j.neuroscience.2008.08.043</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR51</td><td>BibArticle</td><td>Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150(1):76&#8211;85.</td><td><a href=http://dx.doi.org/10.1016/0003-2697(85)90442-7>10.1016/0003-2697(85)90442-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR52</td><td>BibArticle</td><td>Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55&#8211;63.</td><td><a href=http://dx.doi.org/10.1016/0022-1759(83)90303-4>10.1016/0022-1759(83)90303-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR53</td><td>BibArticle</td><td>Lindberg RA, Juan TS, Welcher AA, Sun Y, Cupples R, Guthrie B, Fletcher FA. Cloning and characterization of a specific receptor for mouse oncostatin M. Mol Cell Biol. 1998;18(6):3357&#8211;67.</td><td><a href=http://dx.doi.org/10.1128/MCB.18.6.3357>10.1128/MCB.18.6.3357</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR54</td><td>BibArticle</td><td>Mosley B, De Imus C, Friend D, Boiani N, Thoma B, Park LS, Cosman D. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem. 1996;271(51):32635&#8211;43.</td><td><a href=http://dx.doi.org/10.1074/jbc.271.51.32635>10.1074/jbc.271.51.32635</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR55</td><td>BibArticle</td><td>Gegelashvili G, Dehnes Y, Danbolt NC, Schousboe A. The high-affinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signalling mechanisms. Neurochem Int. 2000;37(2-3):163&#8211;70.</td><td><a href=http://dx.doi.org/10.1016/S0197-0186(00)00019-X>10.1016/S0197-0186(00)00019-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR56</td><td>BibArticle</td><td>Swanson RA, Liu J, Miller JW, Rothstein JD, Farrell K, Stein BA, Longuemare MC. Neuronal regulation of glutamate transporter subtype expression in astrocytes. J Neurosci. 1997;17(3):932&#8211;40.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR57</td><td>BibArticle</td><td>Heinrich PC, Behrmann I, Haan S, Hermanns HM, M&#252;ller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J. 2003;374(Pt 1):1&#8211;20.</td><td><a href=http://dx.doi.org/10.1042/bj20030407>10.1042/bj20030407</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR58</td><td>BibArticle</td><td>Hintzen C, Evers C, Lippok BE, Volkmer R, Heinrich PC, Radtke S, Hermanns HM. Box 2 region of the oncostatin M receptor determines specificity for recruitment of Janus kinases and STAT5 activation. J Biol Chem. 2008;283(28):19465&#8211;77.</td><td><a href=http://dx.doi.org/10.1074/jbc.M710157200>10.1074/jbc.M710157200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR59</td><td>BibArticle</td><td>Wang Y, Robledo O, Kinzie E, Blanchard F, Richards C, Miyajima A, Baumann H. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor. J Biol Chem. 2000;275(33):25273&#8211;85.</td><td><a href=http://dx.doi.org/10.1074/jbc.M002296200>10.1074/jbc.M002296200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR60</td><td>BibArticle</td><td>Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol. 2003;149:1&#8211;38.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1007/s10254-003-0012-2>10.1007/s10254-003-0012-2</a></td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, Author_FamilyName_1, Author_FamilyName_2</td><td>CrossRef</td></tr><tr><td>CR61</td><td>BibArticle</td><td>Thoma B, Bird TA, Friend DJ, Gearing DP, Dower SK. Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. J Biol Chem. 1994;269(8):6215&#8211;22.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR62</td><td>BibArticle</td><td>Repovic P, Benveniste EN. Prostaglandin E2 is a novel inducer of oncostatin-M expression in macrophages and microglia. J Neurosci. 2002;22(13):5334&#8211;43.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR63</td><td>BibArticle</td><td>Hsu MP, Frausto R, Rose-John S, Campbell IL. Analysis of IL-6/gp130 family receptor expression reveals that in contrast to astroglia, microglia lack the oncostatin M receptor and functional responses to oncostatin M. Glia. 2015;63(1):132&#8211;41.</td><td><a href=http://dx.doi.org/10.1002/glia.22739>10.1002/glia.22739</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR64</td><td>BibArticle</td><td>Wang Z, Pekarskaya O, Bencheikh M, Chao W, Gelbard HA, Ghorpade A, Rothstein JD, Volsky DJ. Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology. 2003;312(1):60&#8211;73.</td><td><a href=http://dx.doi.org/10.1016/S0042-6822(03)00181-8>10.1016/S0042-6822(03)00181-8</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR65</td><td>BibArticle</td><td>Schaefer LK, Wang S, Schaefer TS. Oncostatin M activates stat DNA binding and transcriptional activity in primary human fetal astrocytes: low- and high-passage cells have distinct patterns of stat activation. Cytokine. 2000;12(11):1647&#8211;55.</td><td><a href=http://dx.doi.org/10.1006/cyto.2000.0774>10.1006/cyto.2000.0774</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR66</td><td>BibArticle</td><td>Bal-Price A, Brown GC. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci. 2001;21(17):6480&#8211;91.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR67</td><td>BibArticle</td><td>Tilleux S, Hermans E. Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J Neuro Res. 2007;85:2059&#8211;70.</td><td><a href=http://dx.doi.org/10.1002/jnr.21325>10.1002/jnr.21325</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR68</td><td>BibArticle</td><td>Escartin C, Brouillet E, Gubellini P, Trioulier Y, Jacquard C, Smadja C, Knott GW, Kerkerian-Le Goff L, D&#233;glon N, Hantraye P, Bonvento G. Ciliary neurotrophic factor activates astrocytes, redistributes their glutamate transporters GLAST and GLT-1 to raft microdomains, and improves glutamate handling in vivo. J Neurosci. 2006;26(22):5978&#8211;89.</td><td><a href=http://dx.doi.org/10.1523/JNEUROSCI.0302-06.2006>10.1523/JNEUROSCI.0302-06.2006</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR69</td><td>BibArticle</td><td>Beurrier C, Faideau M, Bennouar KE, Escartin C, Kerkerian-Le Goff L, Bonvento G, Gubellini P. Ciliary neurotrophic factor protects striatal neurons against excitotoxicity by enhancing glial glutamate uptake. PLoS One. 2010;5(1):e8550.</td><td><a href=http://dx.doi.org/10.1371/journal.pone.0008550>10.1371/journal.pone.0008550</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR70</td><td>BibArticle</td><td>Nookala AR, Kumar A. Molecular mechanisms involved in HIV-1 Tat-mediated induction of IL-6 and IL-8 in astrocytes. J Neuroinflammation. 2014;11:214.</td><td><a href=http://dx.doi.org/10.1186/s12974-014-0214-3>10.1186/s12974-014-0214-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR71</td><td>BibArticle</td><td>Shah A, Verma AS, Patel KH, Noel R, Rivera-Amill V, Silverstein PS, Chaudhary S, Bhat HK, Stamatatos L, Singh DP, Buch S, Kumar A. HIV-1 gp120 induces expression of IL-6 through a nuclear factor-kappa B-dependent mechanism: suppression by gp120 specific small interfering RNA. PLoS One. 2011;6(6):e21261.</td><td><a href=http://dx.doi.org/10.1371/journal.pone.0021261>10.1371/journal.pone.0021261</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR72</td><td>BibArticle</td><td>Liu X, Kumar A. Differential signaling mechanism for HIV-1 Nef-mediated production of IL-6 and IL-8 in human astrocytes. Sci Rep. 2015;5:9867.</td><td><a href=http://dx.doi.org/10.1038/srep09867>10.1038/srep09867</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR73</td><td>BibArticle</td><td>Gangwani MR, Kumar A. Multiple protein kinases via activation of transcription factors NF-kB, AP-1 and C/EBP-&#948; regulate the IL-6/IL-8 production by HIV-1 Vpr in astrocytes. PLoS One. 2015;10(8):e0135633.</td><td><a href=http://dx.doi.org/10.1371/journal.pone.0135633>10.1371/journal.pone.0135633</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR74</td><td>BibArticle</td><td>Okada K, Yamashita U, Tsuji S. Modulation of Na<Superscript>+</Superscript>-dependent glutamate transporter of murine astrocytes by inflammatory mediators. J UOEH. 2005;27(2):161&#8211;70.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR75</td><td>BibArticle</td><td>Piani D, Frei K, Pfister HW, Fontana A. Glutamate uptake by astrocytes is inhibited by reactive oxygen intermediates but not by other macrophage-derived molecules including cytokines, leukotrienes or platelet-activating factor. J Neuroimmunol. 1993;48(1):99&#8211;104.</td><td><a href=http://dx.doi.org/10.1016/0165-5728(93)90063-5>10.1016/0165-5728(93)90063-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>